Cargando...
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
PURPOSE: B-cell lymphoma 2 (BCL2) is an antiapoptosis protein and an important clinical breast cancer prognostic marker. As the role of BCL2 is dependent on the estrogen receptor (ER) status, this effect might differ according to molecular subtypes. The aim of this study was to evaluate the relation...
Guardado en:
| Publicado en: | J Breast Cancer |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Korean Breast Cancer Society
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053309/ https://ncbi.nlm.nih.gov/pubmed/27721874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2016.19.3.252 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|